Scribd Logo
Upload

Welcome to Scribd!

  • Evaluare risc HAS-BLED și management hemoragie la pacienți tratați cu anticoagulante noi

    Uploaded by

    viorel79
    20 views2 pages
    The document provides guidance on evaluating patients using the HAS-BLED bleeding risk score and managing bleeding in patients treated with new anticoagulants. The HAS-BLED score assigns 1 point each for factors like hypertension, abnormal liver/kidney function, stroke, bleeding history, labile INRs, elderly age (over 65), and use of drugs/alcohol. The management of bleeding depends on its severity from minor to very severe. Minor bleeding involves symptomatic treatment and compression. Moderate to severe bleeding adds fluid replacement and blood transfusion. Very severe bleeding may require recombinant factor VIIa or prothrombin complex concentrate, charcoal filtration, or hemodialysis for dabigatran.

    Original Description:

    pradaxa

    Original Title

    Scor Has -Bled

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document provides guidance on evaluating patients using the HAS-BLED bleeding risk score and managing bleeding in patients treated with new anticoagulants. The HAS-BLED score assigns 1 point each for factors like hypertension, abnormal liver/kidney function, stroke, bleeding history, labile INRs, elderly age (over 65), and use of drugs/alcohol. The management of bleeding depends on its severity from minor to very severe. Minor bleeding involves symptomatic treatment and compression. Moderate to severe bleeding adds fluid replacement and blood transfusion. Very severe bleeding may require recombinant factor VIIa or prothrombin complex concentrate, charcoal filtration, or hemodialysis for dabigatran.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    20 views2 pages

    Evaluare risc HAS-BLED și management hemoragie la pacienți tratați cu anticoagulante noi

    Uploaded by

    viorel79
    The document provides guidance on evaluating patients using the HAS-BLED bleeding risk score and managing bleeding in patients treated with new anticoagulants. The HAS-BLED score assigns 1 point each for factors like hypertension, abnormal liver/kidney function, stroke, bleeding history, labile INRs, elderly age (over 65), and use of drugs/alcohol. The management of bleeding depends on its severity from minor to very severe. Minor bleeding involves symptomatic treatment and compression. Moderate to severe bleeding adds fluid replacement and blood transfusion. Very severe bleeding may require recombinant factor VIIa or prothrombin complex concentrate, charcoal filtration, or hemodialysis for dabigatran.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 2

    Evaluare pacient scor HAS-BLED

    Citerii risc HAS-BLED

    Hypertension
    Abnormal renal or liver
    function (1 point each)

    Scor
    1
    1 or 2

    Stroke

    Bleeding

    Labile INRs

    Elderly

    (e.g. age >65 yrs)

    Drugs or alcohol
    (1 point each)

    1 or 2

    INR = international normalized ratio

    Pisters R et al. Chest. 2010;138:1093100; ESC guidelines: Camm J et al. Eur Heart J 2010;31:2369429

    Managementul hemoragiei
    Pacient tratat cu un nou ACO care prezinta
    o hemoragie
    Se verifica statusul hemodinamic, testele de coagulare de baza cu scopul evaluarii
    efectului anticoagulant
    (de ex. aPTT pentru dabigatran, TP sau activitatea anti-Xa pentru rivaroxaban),
    functia renala, etc
    Se intarzie urmatoarea doza sau se intrerupe
    Minora
    tratamentul

    Moderat-spre-severa

    Tratament simptomatic/ de suport


    Compresie mecanica
    Inlocuire de fluide
    Transfuzie de sange
    Carbune oral daca ingestia este
    recenta*

    Foarte severa

    Se considera FVIIa recombinant


    sau CCP
    Filtare pe carbune*/hemodializa*

    *Cu dabigatran
    aPTT = activated partial thromboplastin time; CCP= concetrat complex de protrombina;
    TP = timpul de protrombina ; FVIIa = Factor VII activat
    Camm AJ et al. Eur Heart J doi:10.1093/eurheartj/ehs253

    You might also like